Want to see IN:SHIVALIK full AI Analyst Report?

Shivalik Rasayan Ltd (SHIVALIK) Price & Analysis

0 Followers

SHIVALIK Stock Chart & Stats

₹358.75

-₹13.65(-1.86%)

At close: Jan 08 4:00 PM EST

₹358.75

-₹13.65(-1.86%)

Day’s Range― - ―

52-Week Range₹206.00 - ₹495.40

Previous CloseN/A

Volume18.40K

Average Volume (3M)1.25K

Market Cap

₹4.92B

Enterprise Value₹7.35K

Total Cash (Recent Filing)₹343.68M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)35.3

Beta0.79

Next Earnings

Nov 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.16%

Share Statistics

EPS (TTM)8.69

Shares Outstanding15,750,365

10 Day Avg. Volume987

30 Day Avg. Volume1,247

Financial Highlights & Ratios

PEG Ratio-1.05

Price to Book (P/B)0.58

Price to Sales (P/S)0.94

P/FCF Ratio-5.96

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Steady Revenue GrowthConsistent top-line expansion indicates resilient demand for the company’s chemical products and supports operating scale. Sustained growth over several years provides a durable foundation, even though future profitability will depend on product mix and cost control.

Conservative LeverageLow leverage and a growing equity base provide financial flexibility to fund operations and investment without excessive dependence on debt. This strengthens resilience through periods of margin pressure or working-capital volatility.

Specialty Chemical B2B ModelSupplying industrial intermediates to pharmaceutical and agrochemical customers gives the business a structurally relevant role in downstream production chains. Customer-specific specifications and bulk B2B supply can support repeat demand and operational specialization.

Bears Say

Persistent Negative Cash FlowPersistently weak cash conversion is a material fundamental risk because reported revenue and earnings are not translating into operating liquidity. Continued negative cash flow may increase reliance on reserves or financing to support investment and day-to-day operations.

Weaker ProfitabilityLower earnings and thinner margins weaken the durability of the company’s growth because expansion is producing less profit than in earlier periods. Sustained pressure from input costs, pricing, or product mix could limit earnings recovery.

Declining EPSNegative EPS growth signals reduced earnings available per share despite the company’s ongoing revenue expansion. If this persists, it can constrain internally funded growth and indicate that operating improvements are not yet translating into stronger shareholder returns.

Shivalik Rasayan Ltd News

Shivalik Rasayan Publishes EGM Voting Results, Highlights Governance Focus

An update from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ) is now available. Shivalik Rasayan Limited disclosed the voting...

8d ago

Shivalik Rasayan Publishes Audited Results for Quarter and Year Ended March 31, 2026

An announcement from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ) is now available. Shivalik Rasayan Limited announced that its...

3M ago

Shivalik Rasayan Limited Publishes Regulatory Advertisements

The latest update is out from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ). Shivalik Rasayan Limited announced the publication...

11M ago

Shivalik Rasayan Announces 47th AGM Details

Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ) has issued an update. Shivalik Rasayan Limited announced the publication of a...

12M ago

SHIVALIK FAQ

What was Shivalik Rasayan Ltd’s price range in the past 12 months?

Shivalik Rasayan Ltd lowest stock price was ₹206.00 and its highest was ₹495.40 in the past 12 months.

What is Shivalik Rasayan Ltd’s market cap?

Shivalik Rasayan Ltd’s market cap is ₹4.92B.

When is Shivalik Rasayan Ltd’s upcoming earnings report date?

Shivalik Rasayan Ltd’s upcoming earnings report date is Nov 06, 2026 which is in 68 days.

How were Shivalik Rasayan Ltd’s earnings last quarter?

Shivalik Rasayan Ltd released its earnings results on Aug 14, 2026. The company reported ₹2.16 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Shivalik Rasayan Ltd overvalued?

According to Wall Street analysts Shivalik Rasayan Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Shivalik Rasayan Ltd pay dividends?

Shivalik Rasayan Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.16%. See more information on Shivalik Rasayan Ltd dividends here

What is Shivalik Rasayan Ltd’s EPS estimate?

Shivalik Rasayan Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shivalik Rasayan Ltd have?

Shivalik Rasayan Ltd has 15,750,365 shares outstanding.

What happened to Shivalik Rasayan Ltd’s price movement after its last earnings report?

Shivalik Rasayan Ltd reported an EPS of ₹2.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.718%.

Which hedge fund is a major shareholder of Shivalik Rasayan Ltd?

Currently, no hedge funds are holding shares in IN:SHIVALIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Shivalik Rasayan Ltd

Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecticides and various other chemicals.